Morning vs. evening infusion: new study tests best time for immunotherapy

This study looks at whether giving immunotherapy at different times of the day changes how well it works for people with a type of esophageal cancer. About 90 patients will be split into three groups based on when they receive their infusion (morning or evening). The goal is to see which timing leads to better tumor shrinkage before surgery. This is a phase 2 trial, meaning it's still early in testing, and it focuses on controlling the disease rather than curing it.